Did you know that the value of the biopharmaceutical industry is expected to grow to $535 billion by 2027?

There’s no getting around the fact that this industry has worked wonders for all types of chronic diseases, among other health conditions. Since there are so many developments happening across the world, it can be tough to keep up. If you’re in the field, it’s worth staying in the loop because this info could revolutionize your practice.

Are you wondering what’s new? Keep reading to learn all about the latest biopharmaceutical industry facts and statistics in 2021.

Northeastern University Wins Biotech Grant

In order to boost the biopharmaceutical market and other industries in various regions of the U.S. after the wake of COVID-19, the Biden administration approved a proposal that came out of Northeastern University.

Half a million dollars will be going toward further research in the biopharmaceutical field. Not only will this bolster labs and community efforts, but it will create thousands of jobs in the process.

This concept of pushing boundaries is shared by Matthew Gline at Roivant Sciences.

An Advancements Series Is Being Launched

If you’ve wanted to learn all about the latest biopharmaceutical products and advancements, then be sure to tune into the new show Advancements with the legendary Ted Danson.

Scheduled to air next year, the show plans to focus on cancer metastasis care. To be more specific, they’ll look at all the latest biomedical technology involved in the process.

Aside from the famous host, you can expect experts in relevant fields to be featured in the various episodes.

Cuba Is Paving The Way

It’s not often that Cuba makes a mark on biopharmaceutical statistics. However, they have almost 15 promising products that they’re prioritizing.

For example, they’re trying new formulas of Herberprot-P as a way to treat foot ulcers brought on by diabetes.

There’s also a trial that’s just beginning for a new vaccine called Cimavax-EGF. This will go a long way toward treating people who are suffering from premalignant lesions.

These are only a couple of the many exciting developments that are underway.

Bionomics Limited Opens DoorsTto US Investors

Bionomics Limited has announced that they are expanding their growth into the United States. They’re doing this by selling American Depositary Shares. For those who don’t know, they’re an Australian biopharmaceutical manufacturer.

This gives more investors an opportunity to get a piece of an already successful pie. Keep in mind that the shares are limited to 1,620,000. One ADS share is equivalent to 180 regular shares in the investment market.

Were You Fascinated By These Biopharmaceutical Industry Facts?

Now that you’ve learned all about the latest biopharmaceutical industry facts and statistics in 2021, you can apply that to your own medical practice. This is an industry that’s constantly changing, so it’s important not to fall behind.

For more valuable information on this topic and many others, be sure to read our other articles. We take pride in publishing high-quality content on a regular basis. This is why you should always check back for more.